Rebalix
iShares · sheet of 10 September 2026
iShares · sheet of 10 September 2026ETF sheet · official issuer and register data
iShares $ Treasury Bond 0-3 Month UCITS ETF
US03 · IE000PBKBK34 · USD · domicile Ireland
Money market · North AmericaSFDR art. 6
Index tracked: ICE 0-3 Month US Treasury Bill Index - Daily rebalance
- TER
- 0.07%+ trans. 0.09%
- Fund size
- 45 m EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 14.66%white list 83.97%
- Replication
- Physical (optimised)
- Income
- Distributingsemi-annual
- Duration
- 0.10 yrsshort (≤3 years)
Launch 24 Sept 2024 · costs from the KID as of 2 Sept 2026 · 0 securities held
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Fund which aims to achieve a total return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the ICE 0-3 Month US Treasury Bill Index, this Fund’s Benchmark Index (“Index”). The Share Class, via the Fund, is passively managed and aims to invest so far as possible and practicable in fixed income (FI) securities (such as bonds)] that make up the Index. The Index is designed to measure the performance of US Dollar denominated fixed income securities issued by the US Treasury that…
Performance since series start (in euro) — base 100
24 Sept 2024 → 31 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +4.4% |
| 3 years | series too young |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +3.9% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 2.76% | 2.76% | — |
| Max drawdown | −1.96% | −1.96% | — |
| Sharpe | -0.84 | -0.84 | — |
| Sortino | -0.88 | -0.88 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · US03 · IE000PBKBK341
RebalixUS03 · IE000PBKBK34 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +4.31% | +4.28% | +0.03% |
Fixed income — as declared by the issuer
Issuer page · 20 Aug 2026 · investment-grade share (BBB−/Baa3 and above): —
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Distributions · per share, in USD
Frequency: semi-annual · last 12 months: 0.19 USD (3.76% of NAV) · last ex-date 18 Jun 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 1 | 0.09 | — |
| 2025 | 2 | 0.21 | +4.18% |
| 2024 | 1 | 0.04 | — |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 31 Aug 2026 · 0 securities · top-10 weight = 0.0%
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE000PBKBK34
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE000PBKBK34
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · US03 · IE000PBKBK342